Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

PHASE1CompletedINTERVENTIONAL
Enrollment

1,756

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 16, 2019

Study Completion Date

December 16, 2019

Conditions
Solid Tumors
Interventions
DRUG

Avelumab

Participants received intravenous infusion of Avelumab in dose escalation and expansion cohorts until confirmed progression, unacceptable toxicity, or any reason for withdrawal from the trial or IMP occurs.

Trial Locations (74)

100

National Taiwan University Hospital, Taipei

704

National Cheng Kung University Hospital, Tainan City

2610

GZA Ziekenhuizen - Campus Sint-Augustinus, Wilrijk

10032

Columbia University College of Phys & Surgeons, New York

10461

Montefiore Medical Center PRIME, The Bronx

13620

Seoul National University Bundang Hospital, Seongnam-si

17033

Penn State Univ. Milton S. Hershey Medical Center - MSHMC Cardiology, Hershey

20057

Georgetown University Medical Center- Research Parent, Washington D.C.

20817

RCCA MD LLC - Bethesda, Bethesda

20850

Maryland Oncology Hematology, P.A., Rockville

20892

National Cancer Institute, Bethesda

27514

University of North Carolina at Chapel Hill, Chapel Hill

28078

Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center, Huntersville

29245

Medical University of South Carolina, Charleston

30060

Northwest Georgia Oncology Centers PC, Marietta

30318

Peachtree Hematology-Oncology Consultants, PC, Atlanta

30607

Northeast Georgia Cancer Care, LLC, Athens

30912

Augusta University - formerly Georgia Regents University, Augusta

33136

University of Miami, Miami

33308

Holy Cross Hospital, Fort Lauderdale

34232

Florida Cancer Specialists, Sarasota

34952

Hematology - Oncology Associates of Treasure Coast - Hematology-Oncology Associates of Treasure Coast, Port Saint Lucie

37203

SCRI - Tennessee Oncology, Nashville

38120

Baptist Cancer Center, Memphis

38138

The West Clinic, Germantown

43219

Mid Ohio Oncology Hematology, DBA The Mark H. Zangmeister Center - d/b/a The Mark H. Zangmeister Center, Columbus

44106

University Hospitals Case Medical Center - Case Comprehensive Cancer Center, Cleveland

47905

Horizon Oncology Research, INC, Lafayette

48201

Karmanos Cancer Institute, Detroit

48202

Henry Ford Medical Center, Detroit

48910

Michigan State University, Lansing

49055

ICO - Site Paul Papin - service d'oncologie medicale, Angers

55131

Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz - I. Medizinische Klinik Gastroenterologie u Hepato., Mainz

55407

Virginia Piper Cancer Institute, Minneapolis

60637

University of Chicago Medical Center, Chicago

63110

Washington University in St. Louis, St Louis

64131

Kansas City Research Institute, LLC - Phase I Unit, Kansas City

67000

Centre Paul Strauss - Service de Médecine Oncologique, Strasbourg

69008

Centre Léon Bérard, Lyon

72758

Highlands Oncology Group, Rogers

73104

Oklahoma University Medical Center, Oklahoma City

75246

Texas Oncology, P.A, Dallas

75702

Texas Oncology, P.A. - Tyler, Tyler

77030

Oncology Consultants, P.A., Houston

78052

Schwarzwald-Baar Klinikum Villingen-Schwenningen GmbH - Innere Medizin II Haematologie / Onkologie, Villingen-Schwenningen

85258

Pinnacle Oncology Hematology, Scottsdale

85338

Cancer Treatment Centers of America - Western Regional Medical Center, Goodyear

87401

San Juan Oncology Associates, Farmington

90025

The Angeles Clinic and Research Institute - West LA, Los Angeles

90048

Cedars-Sinai Medical Center - Oncology, Los Angeles

90305

Healing Hands Oncology and Medical Care, Inglewood

92024

California Cancer Associates for Research & Excellence, Inc, Encinitas

92037

Scripps Health dba Scripps Clinical Research Services, La Jolla

92123

Sharp Memorial Hospital, San Diego

92801

Pacific Cancer Medical Center, Inc., Anaheim

95817

University of California Davis Health System, Sacramento

85258-4550

Scottsdale Healthcare Corporation, Scottsdale

21287-7049

The Johns Hopkins Hospital, Baltimore

45267-0502

UC Health Clinical Trials Office, Cincinnati

43210-1228

OSU - James Comprehensive Cancer Center - Division of Hematology, Columbus

02903

Rhode Island Hospital, Providence

98499-3071

Northwest Medical Specialties, PLLC, Lakewood

256 01

Nemocnice Rudolfa a Stefanie Benesov, a.s., Benešov

06189

Centre Antoine Lacassagne, Nice

02-781

Centrum Onkologii-Instytut im. M. Sklodowskiej Curie - Dept of Digestive System Oncology, Warsaw

02841

Korea University Anam Hospital, Seoul

03080

Seoul National University Hospital, Seoul

03722

Severance Hospital, Yonsei University, Seoul

05505

Asan Medical Center, Seoul

06273

Gangnam Severance Hospital, Yonsei University Health System, Seoul

06351

Samsung Medical Center, Seoul

06591

The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul

W1G 6AD

Sarah Cannon Research Institute UK, London

PL6 8BQ

Derriford Hospital - Dept of Oncology Clinical Trials, Plymouth

All Listed Sponsors
collaborator

Merck KGaA, Darmstadt, Germany

INDUSTRY

lead

EMD Serono Research & Development Institute, Inc.

INDUSTRY

NCT01772004 - Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor) | Biotech Hunter | Biotech Hunter